1. Home
  2. PW vs GOVX Comparison

PW vs GOVX Comparison

Compare PW & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PW

Power REIT (MD)

SELL

Current Price

$7.85

Market Cap

3.4M

Sector

Real Estate

ML Signal

SELL

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$0.77

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PW
GOVX
Founded
1967
2001
Country
United States
United States
Employees
2
19
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PW
GOVX
Price
$7.85
$0.77
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
14.1K
198.4K
Earning Date
05-13-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.12
52 Week High
$12.92
$4.40

Technical Indicators

Market Signals
Indicator
PW
GOVX
Relative Strength Index (RSI) 42.09 33.53
Support Level $0.71 $0.64
Resistance Level $11.62 $2.00
Average True Range (ATR) 0.61 0.09
MACD -0.24 0.01
Stochastic Oscillator 23.44 21.62

Price Performance

Historical Comparison
PW
GOVX

About PW Power REIT (MD)

Power REIT is an internally-managed real estate investment trust that owns a portfolio of real estate assets related to transportation, energy infrastructure and Controlled Environment Agriculture in the United States. Its assets consisted of approximately 112 miles of railroad infrastructure and related real estate which is owned by its subsidiary, approximately 447 acres of fee simple land leased to a utility scale solar power generating project with an aggregate generating capacity of approximately 82 Megawatts and approximately 82 acres of land with approximately 357,000 square feet of CEA properties in the form of greenhouses. The company invested in greenhouses for state-licensed cannabis and food cultivation.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

Share on Social Networks: